Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus

Cases of Type 2 Diabetes Mellitus (T2DM) are increasing at an alarming rate due to the rise in obesity, sedentary lifestyles, glucose-rich diets and other factors. Numerous studies have increasingly illustrated the pivotal role that human islet amyloid polypeptide (hIAPP) plays in the pathology of T...

Full description

Bibliographic Details
Main Authors: Sevcuka, Adriana, White, Kenneth, Terry, Cassandra
Format: Article
Language:English
Published: MDPI 2022
Subjects:
Online Access:https://repository.londonmet.ac.uk/7638/1/life-12-00583.pdf
_version_ 1804072802149466112
author Sevcuka, Adriana
White, Kenneth
Terry, Cassandra
author_facet Sevcuka, Adriana
White, Kenneth
Terry, Cassandra
author_sort Sevcuka, Adriana
collection LMU
description Cases of Type 2 Diabetes Mellitus (T2DM) are increasing at an alarming rate due to the rise in obesity, sedentary lifestyles, glucose-rich diets and other factors. Numerous studies have increasingly illustrated the pivotal role that human islet amyloid polypeptide (hIAPP) plays in the pathology of T2DM through damage and subsequent loss of pancreatic β-cell mass. HIAPP can misfold and form amyloid fibrils which are preceded by pre-fibrillar oligomers and monomers, all of which have been linked, to a certain extent, to β-cell cytotoxicity through a range of proposed mechanisms. This review provides an up-to-date summary of recent progress in the field, highlighting factors that contribute to hIAPP misfolding and aggregation such as hIAPP protein concentration, cell stress, molecular chaperones, the immune system response and cross-seeding with other amyloidogenic proteins. Understanding the structure of hIAPP and how these factors affect amyloid formation will help us better understand how hIAPP misfolds and aggregates and, importantly, help identify potential therapeutic targets for inhibiting amyloidosis so alternate and more effective treatments for T2DM can be developed.
first_indexed 2024-07-09T04:04:56Z
format Article
id oai:repository.londonmet.ac.uk:7638
institution London Metropolitan University
language English
last_indexed 2024-07-09T04:04:56Z
publishDate 2022
publisher MDPI
record_format eprints
spelling oai:repository.londonmet.ac.uk:76382024-02-05T11:42:50Z http://repository.londonmet.ac.uk/7638/ Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus Sevcuka, Adriana White, Kenneth Terry, Cassandra 610 Medicine & health Cases of Type 2 Diabetes Mellitus (T2DM) are increasing at an alarming rate due to the rise in obesity, sedentary lifestyles, glucose-rich diets and other factors. Numerous studies have increasingly illustrated the pivotal role that human islet amyloid polypeptide (hIAPP) plays in the pathology of T2DM through damage and subsequent loss of pancreatic β-cell mass. HIAPP can misfold and form amyloid fibrils which are preceded by pre-fibrillar oligomers and monomers, all of which have been linked, to a certain extent, to β-cell cytotoxicity through a range of proposed mechanisms. This review provides an up-to-date summary of recent progress in the field, highlighting factors that contribute to hIAPP misfolding and aggregation such as hIAPP protein concentration, cell stress, molecular chaperones, the immune system response and cross-seeding with other amyloidogenic proteins. Understanding the structure of hIAPP and how these factors affect amyloid formation will help us better understand how hIAPP misfolds and aggregates and, importantly, help identify potential therapeutic targets for inhibiting amyloidosis so alternate and more effective treatments for T2DM can be developed. MDPI 2022-04-14 Article PeerReviewed text en cc_by_4 https://repository.londonmet.ac.uk/7638/1/life-12-00583.pdf Sevcuka, Adriana, White, Kenneth and Terry, Cassandra (2022) Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus. Life (Basel, Switzerland), 12 (4) (583). pp. 1-19. ISSN 2075-1729 https://doi.org/10.3390/life12040583 10.3390/life12040583
spellingShingle 610 Medicine & health
Sevcuka, Adriana
White, Kenneth
Terry, Cassandra
Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
title Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
title_full Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
title_fullStr Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
title_full_unstemmed Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
title_short Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
title_sort factors that contribute to hiapp amyloidosis in type 2 diabetes mellitus
topic 610 Medicine & health
url https://repository.londonmet.ac.uk/7638/1/life-12-00583.pdf
work_keys_str_mv AT sevcukaadriana factorsthatcontributetohiappamyloidosisintype2diabetesmellitus
AT whitekenneth factorsthatcontributetohiappamyloidosisintype2diabetesmellitus
AT terrycassandra factorsthatcontributetohiappamyloidosisintype2diabetesmellitus